✦ LIBER ✦

A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis

✍ Scribed by Derek Soon; Daniel R. Altmann; Kryshani T.M. Fernando; Garin Giovannoni; Frederick Barkhof; Chris H. Polman; Paul O’Connor; Bruce Gray; Michael Panzara; David H. Miller

Publisher: Springer
Year: 2007
Tongue: English
Weight: 140 KB
Volume: 254
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-006-0356-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized placebo-controlled trial of m

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

✍ E. Millefiorini; C. Gasperini; C. Pozzilli; F. D’Andrea; S. Bastianello; M. Troj 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 44 KB

Efficacy and tolerability of natalizumab

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB

A serial study of peripheral blood T lym

A serial study of peripheral blood T lymphocyte subsets in relapsing–remitting multiple sclerosis

✍ Lorne F. Kastrukoff; Donald W. Paty 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp

The effect of interferon-β on blood—brai

The effect of interferon-β on blood—brain barrier disruptions demonstrated by constrast-enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis

✍ Lael A. Stone; Joseph A. Frank; Paul S. Albert; Craig Bash; Mary E. Smith; Heidi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 889 KB

The effect of natalizumab on cognitive f

The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study

✍ Flavia Mattioli; C. Stampatori; R. Capra 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 164 KB